TITLE

Scrip spending slows

PUB. DATE
May 2004
SOURCE
GP: General Practitioner;5/3/2004, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The rise in prescribing costs in England has slowed, despite steady growth in prescribing volume, according to the Prescription Pricing Authority (PPA). GPC prescribing subcommittee chairman Dr. Peter Fellows attributed the slowed growth to certain drugs coming off patent. PPA data also showed an unexpected fall in prescribing of anti-obesity drugs.
ACCESSION #
13053736

 

Related Articles

  • Prescribing data shows slowdown in drug spending. Polak, Monika // GP: General Practitioner;5/3/2004, p5 

    The increase in prescribing costs has slowed down, according to data from the Prescription Pricing Authority (PPA) published last week. The PPA prescribing cost analysis for 2003 showed that almost 650 million prescription items were dispensed in 2003, costing just over pounds 7.51 billion....

  • 'Irrational' prescription system must be changed.  // British Journal of Nursing;1/10/2002, Vol. 11 Issue 1, p11 

    Reports the need for changing prescription charging system in Great Britain. Description of the system; Trend of prescribing smaller containers of drugs at one time; Factors contributing to ill health.

  • Understanding drug pricing. Silver, Lisa // GP: General Practitioner;5/2/2008, p38 

    The article discusses the significance of "Drug Tariff" to dispensing doctors in Great Britain. It is published monthly by the Prescription Pricing Division and is advantageous to physicians because it can help every dispensing doctor ensure that their practice does not lose out on price changes...

  • Scrip charges survive in Scotland.  // GP: General Practitioner;2/10/2006, p24 

    The article states that the Scottish Parliament has rejected a motion to abolish prescription charges in Scotland. However, ministers in the executive have promised to reform the system and introduce more exemptions for chronic conditions, students and those on low incomes.

  • A prescription for controversy. Markels, Alex // U.S. News & World Report;10/6/2003, Vol. 135 Issue 11, p50 

    Discusses the mail order prescription company, Rx Depot, started by entrepreneur Carl Moore. How Moore took advantage of the FDA's seemingly lax enforcement of a law barring the importation of foreign drugs, particularly those from Canada; Set up of Rx Depot in a vacated ATM stall in Oklahoma;...

  • Flat packs. Jones, Andy // Pulse;11/19/2005, Vol. 65 Issue 45, p26 

    The article presents thoughts and opinions of the author regarding the prescription charges in Great Britain. Essentially prescription charges are a flat tax paid by working people regardless of means. The author contends that prescription items per patient are increasing slowly and steadily...

  • Warnings added on posicor.  // FDA Consumer;Mar/Apr98, Vol. 32 Issue 2, p3 

    Warns doctors to take precautions when prescribing the hypertension and chronic angina drug Posicor (mibefradil). Some of the warnings added to Posicor's labeling; Why doctors should not prescribe Posicor to patients on lovastatin or simvastatin.

  • Prescribing update. Saunders, Carol S. // Patient Care for the Nurse Practitioner;Mar2001, Vol. 4 Issue 3, p8 

    Presents an update on prescription drugs as of March 2001. Prescription drugs approved; Indications approved; Formulation approved.

  • DIAGNOSTIC AGENTS.  // MPR - Residents' Edition;Spring/Summer2009, Vol. 18 Issue 1, p87 

    The article offers a guideline in the right prescription of drugs.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics